1. Home
  2. DRCT vs BBLG Comparison

DRCT vs BBLG Comparison

Compare DRCT & BBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Direct Digital Holdings Inc.

DRCT

Direct Digital Holdings Inc.

HOLD

Current Price

$3.42

Market Cap

2.6M

Sector

Technology

ML Signal

HOLD

BBLG

Bone Biologics Corp

HOLD

Current Price

$1.26

Market Cap

2.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRCT
BBLG
Founded
2018
2004
Country
United States
United States
Employees
N/A
2
Industry
Computer Software: Programming Data Processing
Industrial Specialties
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6M
2.3M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
DRCT
BBLG
Price
$3.42
$1.26
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$32.00
N/A
AVG Volume (30 Days)
265.8K
6.5K
Earning Date
05-08-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$34,694,000.00
N/A
Revenue This Year
$5.42
N/A
Revenue Next Year
$9.50
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.04
$0.74
52 Week High
$7.21
$5.98

Technical Indicators

Market Signals
Indicator
DRCT
BBLG
Relative Strength Index (RSI) 53.80 51.60
Support Level $3.08 $1.08
Resistance Level $6.04 $1.40
Average True Range (ATR) 0.63 0.06
MACD -0.18 -0.01
Stochastic Oscillator 8.46 38.89

Price Performance

Historical Comparison
DRCT
BBLG

About DRCT Direct Digital Holdings Inc.

Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.

About BBLG Bone Biologics Corp

Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.

Share on Social Networks: